The GalD Assay is a quantitative ELISA test for measuring serum levels of galactose-deficient IgA1 (Gd-IgA1) in patients with IgA nephropathy. This assay supports research and clinical evaluation, aiding in the development of targeted therapies and monitoring treatment response.